Cyclic Nucleotide Phosphodiesterases: Gene Complexity, Regulation by Phosphorylation, and Physiological Implications

Advances in Pharmacology

Volumn 36, Issue C, 1996, Pages 29-48

  Burns, Fiona ^a   Zhao, Allan Z ^a   Beavo, Joseph A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV;

ANIMAL; CENTRAL NERVOUS SYSTEM; CLASSIFICATION; ENZYME ACTIVATION; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; RAT; REVIEW;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVATION; GENE EXPRESSION; MICE; PHOSPHODIESTERASE I; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORYLATION; RATS;

EID: 0030367929     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60575-X     Document Type: Article

References (107)

1. Ahn H.S., Crim W., Pitts B., and Sybertz E.J. Calcium-calmodulin-stimulated and cyclic-GMP-specific phosphodiesterases. Tissue distribution, drug sensitivity, and regulation of cyclic GMP levels. Adv. Second Messenger Phosphoprotein Res. 25 (1992) 271-288
2. Beavo J.A. Multiple isozymes of cyclic nucleotide phosphodiesterase. Adv. Second Messenger Phosphoprotein Res. 22 (1988) 1-38
3. Beavo J.A., Conti M., and Heaslip R.J. Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46 (1994) 399-405
4. Bentley J.K., and Beavo J.A. Regulation and function of cyclic nucleotides. Curr. Opin. Cell. Biol. 4 (1992) 233-240
5. Bentley J.K., Kadlecek A., Sherbert C.H., Seger D., Sonnenburg W.H., Novack J.P., and Beavo J.A. Molecular cloning of cDNA encoding a "63"-kDa calmodulin-stimulated phosphodiesterase from bovine brain. J. Biol. Chem. 267 (1992) 18676-18682
6. Boekhoff I., and Breer H. Termination of second messenger signaling in olfaction. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 471-474
7. Boekhoff I., Schleicher S., Strotmann J., and Breer H. Odor-induced phosphorylation of olfactory cilia proteins. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 11983-11987
8. Borisy F.F., Ronnett G.V., Cunningham A.M., Juilfs D., Beavo J., and Snyder S.H. Calcium/calmodulin-activated phosphodiesterase expressed in olfactory receptor neurons. J. Neurosci. 12 (1992) 915-923
9. Boyes S., and Loten E.G. Purification of an insulin-sensitive cyclic AMP phosphodiesterase from rat liver. Eur. J. Biochem. 174 (1988) 303-309
10. Breer H., Boekhoff I., and Tareilus E. Rapid kinetics of second messenger formation in olfactory transduction. Nature 345 (1990) 65-68
11. Burns F., and Pyne N.J. Interaction of the catalytic subunit of protein kinase A with the lung type V cyclic GMP phosphodiesterase: Modulation of non-catalytic binding sites. Biochem. Biophys. Res. Commun. 189 (1992) 1389-1396
12. Burns F., Rodger I.W., and Pyne N.J. The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung. Biochem. J. 283 (1992) 487-491
13. Conti M., Swinnen J.V., Tsikalas K.E., and Jin S.L. Structure and regulation of the rat high-affinity cyclic AMP phosphodiesterases. A family of closely related enzymes. Adv. Second Messenger Phosphoprotein Res. 25 (1992) 87-99
14. Davis R.L., Takayasu H., Eberwine M., and Myres J. Cloning and characterization of mammalian homologs of the Drosophila dunce + gene. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 3604-3608
15. Dawson T.M., Arriza J.L., Jaworsky D.E., Borisy F.F., Attramadal H., Lefkowitz R.J., and Ronnett G.V. Beta-adrenergic receptor kinase-2 and beta-arrestin-2 as mediators of odorant-induced desensitization. Science 259 (1993) 825-829
16. Degerman E., Belfrage P., Newman A.H., Rice K.C., and Manganiello V.C. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand. J. Biol. Chem. 262 (1987) 5797-5807
17. Degerman E., Manganiello V.C., Newman A.H., Rice K.C., and Belfrage P. Purification, properties and polyclonal antibodies for the particulate, low Km cAMP phosphodiesterase from bovine adipose tissue. Second Messengers Phosphoproteins 12 (1988) 171-182
18. Degerman E., Smith C.J., Tornqvist H., Vasta V., Belfrage P., and Manganiello V.C. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 533-537
19. Delmas V., and Sassone-Corsi P. The key role of CREM in the CAMP signaling pathway in the testis. Mol. Cell. Endocrinol. 100 (1994) 121-124
20. Dent G., Giembycz M.A., Rabe K.F., and Barnes P.J. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors. Br. J. Pharmacol. 103 (1991) 1339-1346
21. Dumont J.E., Lamy F., Roger P., and Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72 (1992) 667-694
22. Edelman A.M., Raese J.D., Lazar M.A., and Barchas J.D. Tyrosine hydroxylase: Studies on the phosphorylation of a purified preparation of the brain enzyme by the cyclic AMP-dependent protein kinase. J. Pharmacol. Exp. Ther. 216 (1981) 647-653
23. Epstein P.M., Strada S.J., Sarada K., and Thompson W.J. Catalytic and kinetic properties of pursed high-affinity cyclic AMP phosphodiesterase from dog kidney. Arch. Biochem. Biophys. 218 (1982) 119-133
24. Endoh M., Kawabata Y., and Katano Y. PDE isozyme specific regulation of cardiac cyclic AMPand contractility in mammalian myocardium: Clinical relevance. Jpn. J. Pharmacol. 67 (1995) 43 (Suppl. I)
25. Florio V.A., Sonnenburg W.K., Johnson R., Kwak K.S., Jensen G.S., Walsh K.A., and Beavo J.A. Phosphorylation of the 61-kDa calmodulin-stimulated cyclic nucleotide phosphodiesterase at serine 120 reduces its affinity for calmodulin. Biochemistry 33 (1994) 8948-8954
26. Francis S.H., and Corbin J.D. Purification of cGMP-binding protein phosphodiesterase from rat lung. Methods Enzymol. 159 (1988) 722-729
27. Francis S.H., Lincoln T.M., and Corbin J.D. Characterization of a novel cGMP binding protein from rat lung. J. Biol. Chem. 255 (1980) 620-626
28. Francis S.H., Thomas M.K., and Corbin J.D. Cyclic GMP-binding cyclic GMP-specific phosphodiesterase from lung. In: Beavo J., and Houslay M.D. (Eds). "Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action" (1990), Wiley, Chichester, UK 117-140
29. Geremia R., Rossi P., Mocini D., Pezzotti R., and Conti M. Characterization of a calmodulin-dependent high-affinity cyclic AMP and cyclic GMP phosphodiesterase from male mouse germ cells. Biochem. J. 217 (1984) 693-700
30. Gettys T.W., Vine A.J., Simonds M.F., and Corbin J.D. Activation of the particulate low Km phosphodiesterase of adipocytes by addition of cAMP-dependent protein kinase. J. Biol. Chem. 263 (1988) 10359-10363
31. Gillespie P.G., and Beavo J.A. CGMP is tightly bound to bovine retinal rod phosphodi-esterase. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 4311-4315
32. Grant P.G., and Colman R.W. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry 23 (1984) 1801-1807
33. Grant P.G., Mannarino A.F., and Colman R.W. CAMP-mediated phosphorylation of the low-Km CAMP phosphodiesterase markedly stimulates its catalytic activity. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9071-9075
34. Greengard P. Neuronal phosphoproteins. Mol. Neurobiol. 1 (1987) 81-119
35. Hamet P., Coquil J.F., Bousseau L.S., Franks D.J., and Tremblay J. Cyclic GMP binding and phosphodiesterase: Implication for platelet function. Adv. Cyclic Nucleotide Protein Phosphoylation Res. 16 (1984) 119-136
36. Hansen R.S., and Beavo J.A. Purification of two calciundcalmodulin dependent forms of cyclic nucleotide phosphodiesterase by using conformation-specific monoclonal antibody chromatography. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 2788-2792
37. 2+/calmodulin-dependent protein kinases. Annu. Rev. Biochem. 61 (1992) 559-601
38. Harrison S.A., Reifsnyder D.H., Gallis B., Cadd G.G., and Beavo J.A. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: A receptor for new cardiotonic drugs. Mol. Pharmacol. 29 (1986) 506-514
39. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 264 (1989) 10884-10887
40. Heyworth C.M., Wallace A.V., and Houslay M.D. Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes. Biochem. J. 214 (1983) 99-110
41. Houslay M.D., and Lobban M. Distinct brain region distribution patterns for the expression of the type-IV cyclic AMP phosphodiesterase (rPDE-IVB1), PDE-4 (rPDE-IVB2), RD1 (rPDE-IVA1) and the identification of a novel species "OLF-RD1" (rPDEIVA2). FASEB J. 8 (1994) A369
42. Jaworsky D.E., Natsuzaki O., Borisy F.F., and Ronnett G.V. Calcium modulates the rapid kinetics of the odorant-induced cyclic AMP signal in rat olfactory cilia. J. Neurosci. 15 (1995) 310-318
43. Kandel E.R., and Schwartz J.H. Molecular biology of learning: Modulation of transmitter release. Science 218 (1982) 433-443
44. Kauffman R.F., Schenck K.W., Utterback B.G., Crowe V.G., and Cohen M.L. In vitro vascular relaxation by new inotropic agents: Relationship to phosphodiesterase inhibition and cyclic nucleotides. J. Pharmacol. Exp. Ther. 242 (1987) 864-872
45. Livi G.P., Kmetz P., McHale M.M., Cieslinski L.B., Sathe G.M., Taylor D.P., Davis R.L., Torphy T.J., and Balcarek J.M. Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase. Mol. Cell. Biol. 10 (1990) 2678-2686
46. Lobban M., Shakur Y., Beattie J., and Houslay M.D. Identification of two spliced variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: Selective localization in membrane and cytosolic compartments and differential expression in various brain regions. Biochem. J. 304 (1994) 399-406
47. Loughney K., Martins T.J., Harris E.A.S., Sadhu K., Hicks J.B., Sonnenburg W.K., Beavo J.A., and Ferguson K. Isolation and characterization of cDNAs corres-ponding to two human calcium, calmodulin-regulated, 3',5'-cyclic nucleotide phosphodi-esterases. J. Biol. Chem. 271 (1996) 796-806
48. Lugnier C., Schoeffter P., Le B.A., Strouthou E., and Stoclet J.C. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem. Pharmacol. 35 (1986) 1743-1751
49. Macphee C.H., Harrison S.H., and Beavo J.A. Immunological identification of the major platelet low-Km cAMP phosphodiesterase: Probable target for anti-thrombotic agents. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 6660-6663
50. Macphee C.H., Reifsnyder D.H., Moore T.A., Lerea K.M., and Beavo J.A. Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets. J. Biol. Chem. 263 (1988) 10353-10358
51. Malta E. Biphasic relaxant curves to glyceryl trinitrate in rat aortic rings. Evidence for two mechanisms of action. Naunyn Schmiedebergs Arch. Pharmacol. 339 (1989) 236-243
52. Manganiello V., and Vaughn M. An effect of insulin on cAMP phosphodiesterase activity in fat cells. J. Biol. Chem. 248 (1973) 7164-7170
53. Manganiello V.C., Degerman E., Smith C.J., Vasta V., Tornqvist H., and Belfrage P. Mechanisms for activation of the rat adipocyte particulate cyclic-GMP-inhibited cyclic AMP phosphodiesterase and its importance in the antilipolytic action of insulin. Adv. Second Messenger Phosphoprotein Res. 25 (1992) 147-164
54. Manganiello V.C., Degerman E., Smith C.J., Vasta V., Tornqvist H., and Belfrage P. Mechanisms for activation of the rat adipocyte particulate cyclic-GMP-inhibited cyclic AMP phosphodiesterase and its importance in the antilipolytic action of insulin. Adv. Second Messenger Phosphoprotein Res. 25 (1992) 147-164
55. Marchmont R.J., Ayad S.R., and Houslay M.D. Purification and properties of the insulin-stimulated phosphodiesterase from rat liver plasma membranes. Biochem. J. 195 (1981) 645-652
56. Maurice D.H., and Haslam R.J. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: Inhibition of cyclic AMP breakdown by cyclic GMP. Mol. Pharmacol. 37 (1990) 671-681
57. McAllister L.L.M., Sonnenburg W.K., Kadlecek A., Seger D., Trong H.L., Colbran J.L., Thomas M.K., Walsh K.A., Francis S.H., Corbin J.D., and Beavo J.A. The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J. Biol. Chem. 268 (1993) 22863-22873
58. McAllister-Lucas L.M., Haik T.L., Colbran J.L., Sonnenburg W.K., Seger D., Beavo J.A., Francis S.H., and Corbin J.D. Mutagenesis of a lung cGMP-specific phosphodiesterase provides evidence for two distinct sites for allosteric cGMP-binding with an essential aspartic acid at each site. FASEB J. 8 (1994) A372
59. McLaughlin M.M., Cieslinski L.B., Burman M., Torphy T.J., and Livi G.P. A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA. J. Biol. Chem. 268 (1993) 6470-6476
60. Meacci E., Moos M., Taira M., Smith C.J., Vasta V., Degerman E., Movsesian M.A., Belfrage P., and Manganiello V.C. Cloning of cDNA for a human cardiac cGMP-inhibited low Km cAMP phosphodiesterase (CGI PDE). FASEB J. 5 (1991) A454
61. Monaco L., Vicini E., and Conti M. Structure of 2 rat genes coding for closely related rolipram-sensitive cAMP phosphodiesterases-Multiple messenger RNA variants originate from alternative splicing and multiple start sites. J. Biol. Chem. 269 (1994) 347-357
62. Mumby M.C., Martins T.J., Chang M.L., and Beavo J.A. Identification of cGMP-stimulated cyclic nucleotide phosphodiesterase in lung tissue with monoclonal antibodies. J. Biol. Chem. 257 (1982) 13283-13290
63. Nagamine Y., and Reich E. Gene expression and cAMP. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 4606-4610
64. Nestler E.J., and Greengard P. Protein phosphorylation in the brain. Nature 305 (1983) 583-588
65. Obernolte R., Bhakta S., Alvarez R., Bach C., Zuppan P., Mulkins M., Jarnagin K., and Shelton E.R. The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family. Gene 129 (1993) 239-247
66. Pang D.C. Tissue and species specificity of cardiac cAMP-phosphodiesterase inhibitors. Adv. Second Messenger Phosphoprotein Res. 25 (1992) 307-320
67. Peachell P.T., Undem B.J., Schleimer R.P., MacGlashan D.W.J., Lichtenstein L.M., Cieslinski L.B., and Torphy T.J. Preliminary identification and role of phosphodiesterase isozymes in human basophils. J. Immunol. 148 (1992) 2503-2510
68. Pyne N.J., Cooper M.E., and Houslay M.D. The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity. Biochem. J. 242 (1987) 33-42
69. Pyne N.J., Cushley W., Nimmo H.G., and Houslay M.D. Insulin stimulates the tyrosyl phosphorylation and activation of the 52 kDa peripheral plasma-membrane cyclic AMP phosphodiesterase in intact hepatocytes. Biochem. J. 261 (1989) 897-904
70. Rasćon A., Lindgren S., Stavenow L., Belfrage P., Andersson K.E., Manganiello V.C., and Degerman E. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle. Biochim. Biophys. Acta 1134 (1992) 149-156
71. Rasćon A., Degerman E., Taira M., Meacci E., Smith C.J., Manganiello V., Belfrage P., and Tornqvist H. Identification of the phosphorylation site in vitro for cAMP-dependent protein kinase on the rat adipocyte cGMP-inhibited cAMP phosphodiesterase. J. Biol. Chem. 269 (1994) 11962-11966
72. Rossi P., Giorgi M., Geremia R., and Kincaid R.L. Testis-specific calmodulin-dependent phosphodiesterase. A distinct high affinity cAMP isoenzyme immunologically related to brain calmodulin-dependent cGMP phosphodiesterase. J. Biol. Chem. 263 (1988) 15521-15527
73. Rossi P., Pezzotti R., Conti M., and Geremia R. Cyclic nucleotide phosphodiesterases in somatic and germ cells of mouse seminiferous tubules. J. Reprod. Fertil. 74 (1985) 317-327
74. Sarvey J.M., Burgard E.C., and Decker G. Long-term potentiation: Studies in the hippocampal slice. J. Neurosci. Methods 28 (1989) 109-124
75. Schleicher S., Boekhoff I., Arriza J., Lefkowitz R.J., and Breer H. A beta-adrenergic receptor kinase-like enzyme is involved in olfactory signal termination. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1420-1424
76. Schoffelmeer A.N., Warden G., and Mulder A.H. Cyclic AMP facilitates the electrically evoked release of radiolabelled noradrenaline, dopamine and 5-hydroxytrypt-amine from rat brain slices. Naunyn Schmiedebergs Arch. Pharmacol. 330 (1985) 74-76
77. Sette C., Iona S., and Conti M. The short-term activation of the rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J. Biol. Chem. 269 (1994) 9245-9252
78. Sette C., Vicini E., and Conti M. Modulation of cellular responses by hormones-Role of cAMP specific, rolipram-sensitive phosphodiesterases. Mol. Cell. Endocrinol. 100 (1994) 75-79
79. Sette C., Vicini E., and Conti M. The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase. J. Biol. Chem. 269 (1994) 18271-18274
80. Shakur Y., Pryde J.G., and Houslay M.D. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram. Biochem. J. 292 (1993) 677-686
81. Sharma R.K., and Wang J.H. Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 2603-2607
82. 2+-dependent phosphorylation and dephosphorylation of the 63-kDa subunit-containing bovine brain calmodulin-stimulated cyclic nucleotide phosphodiesterase isozyme. J. Biol. Chem. 261 (1986) 1322-1328
83. Sharma R.K., Adachi A.M., Adachi K., and Wang J.H. Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies. J. Biol. Chem. 259 (1984) 9248-9254
84. 2+-calmodu-lin-stimulated cyclic GMP phosphodiesterase from bovine brain. Biochemistry 24 (1985) 672-678
85. Smith C.J., Vasta V., Degerman E., Belfrage P., and Manganiello V.C. Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulin- and cAMP-dependent activation by phosphorylation. J. Biol. Chem. 266 (1991) 13385-13390
86. Sonnenburg W.K., Seger D., and Beavo J.A. Molecular cloning of a cDNA encoding the "61-kDa" calmodulin-stimulated cyclic nucleotide phosphodiesterase. Tissue-specific expression of structurally related isoforms. J. Biol. Chem. 268 (1993) 645-652
87. Souness J.E., Carter C.M., Diocee B.K., Hassall G.A., Wood L.J., and Turner N.C. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. Biochem. Pharmacol. 42 (1991) 937-945
88. Stroop S.D., and Beavo J.A. Structure and function studies of the cGMP-stimulated phosphodiesterase. J. Biol. Chem. 266 (1991) 23802-23809
89. Swinnen J.V., Joseph D.R., and Conti M. Molecular cloning of rat homologues of the Drosophila melanogaster dunce cAMP phosphodiesterase: Evidence for a family of genes. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5325-5329
90. Swinnen J.V., Joseph D.R., and Conti M. The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 8197-8201
91. Taira M., Meacci E., and Manganiello V.C. Two distinct cDNAs of cGMP-inhibited low Km cAMP phosphodiesterase (cGI-PDE) from rat adipose tissue and human heart. Pharmacologist 33 (1991) 190
92. Takemoto D.J., Gonzalez K., Undovichenko J., and Cunnick J. Cyclic GMP-regulated cyclic nucleotide phosphodiesterases. Cell. Signalling 5 (1993) 549-553
93. Thomas M.K., Francis S.H., and Corbin J.D. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J. Biol. Chem. 265 (1990) 14964-14970
94. Thomas M.K., Francis S.H., and Corbin J.D. Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP. J. Biol. Chem. 265 (1990) 14971-14978
95. Thompson W.J., Shen C.C., and Strada S.J. Preparation of dog kidney high-affinity cAMP phosphodiesterase. Methods Enzymol. 159 (1988) 760-766
96. Torphy T.J., Zhou H.L., Burman M., and Huang L.B. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis. Mol. Pharmacol. 39 (1991) 376-384
97. Torphy T.J., Zhou H.L., and Cieslinski L.B. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J. Pharmacol. Exp. Ther. 263 (1992) 1195-1205
98. Turner N.C., Wood L.J., Burns F.M., Gueremy T., and Souness J.E. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Br. J. Pharmacol. 108 (1993) 876-883
99. Weishaar R.E., Kobylarz S.D., Quade M.M., Steffen R.P., and Kaplan H.R. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility. J. Cyclic Nucleotide Protein Phosphor. Res. 11 (1986) 513-527
100. Weishaar R.E., Kobylarz S.D.C., and Kaplan H.R. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle. J. Mol. Cell. Cardiol. 19 (1987) 1025-1036
101. Wilkins M.R., Settle S.L., and Needleman P. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation. J. Clin. Invest. 85 (1990) 1274-1279
102. Wyatt T.A., Francis S.H., McAllister-Lucas L.M., Naftilan A.J., and Corbin J.D. Phosphorylation of cGMP-binding cGMP-specific phosphodiesterase in vascular smooth muscle. FASEB J. 8 (1994) A2150
103. Yamamoto K.K., Gonzalez G.A., Biggs III W.H., and Montminy M.R. Phosphory-lation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334 (1988) 494-498
104. Yan C., and Beavo J.A. Molecular cloning and cellular distribution of the 75 kDa calmodulin-dependent phosphodiesterase. FASEB J. 8 (1994) A81
105. Yan C., Bentley J.K., Sonnenburg W.K., and Beavo J.A. Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain. J. Neurosci. 14 (1993) 973-984
106. Yan C., Zhao A.Z., Bentley J.K., Loughney K., Ferguson K., and Beavo J.A. Molecular cloning and characterization of a novel calmodulin-dependent phosphodiesterase highly enriched in olfactory sensory neurons. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9677-9681
107. Zinman B., and Hollenberg C.H. Effect of insulin and lipolytic agents on rat adipocyte low Km phosphodiesterase. J. Biol. Chem. 249 (1974) 2182-2187